Virginia Board of Medicine Practitioner Information

Home Icon Home

Search Icon Search

Disclaimer Icon Disclaimers

Links Icon Links

Glossary Icon Glossary

Help Icon Questions


Printer Friendly Version Printer Icon
 

Matthew Marvin Hitchcock, MD

LICENSE # 0101265480
 
Issue Date: 9/4/2018
Expiration Date: 1/31/2026
Status: Current Active


General InformationEducationCertifications & Practice AreaInsuranceHonors & AwardsAcademic Appointments & PublicationsProceedings, Actions & ConvictionsPaid Claims
Unless otherwise indicated, this information has been self-reported and has not been verified by the Board of Medicine.


Academic Appointments
Last Updated 1/17/2024
Virginia Commonwealth University School Of Medicine (Previously MCV) - Richmond VA
Rank: Assistant Professor
Years: 2019-Present

Academic Appointments - Non-US
Last Updated 1/17/2024
None Reported
Publications
(up to ten in the last five years)
Last Updated 1/17/2024
Is Follow-Up Testing with the FilmArray Gastrointestinal Multiplex Panel Necessary?
Journal of Clinical Microbiology
Volume: 55
Date: 04 2017

Low Yield of FilmArray GI Panel in Hospitalized Patients with Diarrhea: an Opportunity for Diagnostic Stewardship Intervention
Journal of Clinical Microbiology
Volume: 56
Date: 03 2018

Reproducibility of positive results for rare pathogens on the FilmArray GI Panel
Diagnostic Microbiology and Infectious Disease
Volume: 95
Date: 09 2019
www.sciencedirect.com/science/article/abs/pii/S0732889319300860

Dual reporting of Clostridioides difficile PCR and predicted toxin result based on PCR cycle threshold reduces treatment of toxin-negative patients without increases in adverse outcomes
Journal of Clinical Microbiology
Volume: 57
Date: 10 2019
journals.asm.org/doi/full/10.1128/JCM.01288-19

Diagnostic stewardship approaches to Clostridioides difficile infection in the era of two-step testing: a shifting landscape
Current Treatment Options in Infectious Diseases
Volume: 12
Date: 05 2020
link.springer.com/article/10.1007%2Fs40506-020-00223-8

Discontinuation patterns and cost avoidance of a pharmacist-driven methicillin-resistant Staphylococcus aureus nasal polymerase chain reaction testing protocol for de-escalation of empiric vancomycin for suspected pneumonia
Open Forum Infectious Diseases
Volume: 8
Date: 03 2021
academic.oup.com/ofid/article/8/4/ofab099/6158190

Impact of cascade reporting of antimicrobial susceptibility on fluoroquinolone and meropenem consumption at a Veterans Affairs medical center
Infection Control and Hospital Epidemiology
Date: 04 2021
www.cambridge.org/core/journals/infection-control-and-hospital-epidemiology/article/abs/impact-of-ca

Effect of rapid methicillin-resistant Staphylococcus aureus nasal polymerase chain reaction screening on vancomycin use in the intensive care unit
American Journal of Health-System Pharmacy
Volume: 78
Date: 07 2021
academic.oup.com/ajhp/article/78/24/2236/6326534?login=true

Cost-effectiveness of bezlotoxumab and fidaxomicin for initial Clostridioides difficile infection
Clinical Microbiology and Infection
Volume: 27
Date: 10 2021
www.sciencedirect.com/science/article/abs/pii/S1198743X21001877

Clinical outcomes of treated and untreated C. difficile PCR-positive/toxin-negative adult hospitalized patients: a quasi-experimental noninferiority study
Journal of Clinical Microbiology
Volume: 60
Date: 06 2022